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ABSTRACT
Objective: We evaluated the effects of calcium pyruvate supplementation during training on body composition and
metabolic responses to exercise.
Method: Twenty-three untrained females were matched and assigned to ingest in a double blind and randomized
manner either 5 g of calcium pyruvate (PYR) or a placebo (PL) twice daily for 30 d while participating in a supervised exercise program. Prior to and following supplementation, subjects had body composition determined via hydrodensiometry; performed a maximal cardiopulmonary exercise test; and performed a 45-min walk test at 70% of
pre-training VO2 max in which fasting pre- and post exercise blood samples determined.
Results: No significant differences were observed between groups in energy intake or training volume. Univariate
repeated measures ANOVA revealed that subjects in the PYR group gained less weight (PL 1.2 ± 0.3, PYR 0.3 ± 0.3
kg, P = 0.04), lost more fat (PL 1.1 ± 0.5; PYR −0.4 ± 0.5 kg, P = 0.03), and tended to lose a greater percentage of
body fat (PL 1.0 ± 0.7; PYR −0.65 ± 0.6%, P = 0.07), with no differences observed in fat-free mass (PL 0.1 ± 0.5;
PYR 0.7 ± 0.3 kg, P = 0.29). However, these changes were not significant when body composition data were analyzed by MANOVA (P = 0.16). There was some evidence that PYR may negate some of the beneficial effects of
exercise on HDL values. No significant differences were observed between groups in maximal exercise responses or
metabolic responses to submaximal walking.
Conclusions: Results indicate that PYR supplementation during training does not significantly affect body composition or exercise performance and may negatively affect some blood lipid levels.
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INTRODUCTION
Pyruvate is a three-carbon compound that serves
as the gateway compound between the glycolysis
pathway and the Krebs cycle. During highintensity anaerobic exercise, the pyruvate that is
formed from the breakdown of sugars and amino
acids is converted into lactate by lactate dehy2!!!!!DIGITALCOMMONS@WSU | 2005!

drogenase. Under aerobic conditions, the pyruvate is shuttled into the mitochondria, where it
is converted in acetyl coenzyme A by the pyruvate dehydrogenase complex. Several previous
studies have indicated that calcium and/or sodium pyruvate supplementation enhances weight
and fat loss and improves exercise capacity primarily in overweight individuals (1), (2), (3) and
(4). Hence, pyruvate has recently become a
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popular weight-loss supplement and proposed
ergogenic aid.
However, these claims have been based on a
small number of studies primarily emanating
from one laboratory. For example, Stanko et al.
(1) investigated the effects of pyruvate supplementation on body composition alterations in
morbidly obese women who were housed in a
metabolic ward for 21 d. Subjects were restricted
from performing any exercise while consuming
hypocaloric diets ranging from 2.1 to 4.25 MJ/d.
Subjects were fed in a double blind and randomized manner with pyruvate or glucose to account
for 13% or 20% of daily energy intake (∼16 g/d),
respectively. Results indicated that subjects fed
pyruvate exhibited greater weight loss and fat
loss, with no changes in lean body mass. This
research group also reported that large doses of
calcium pyruvate (i.e., 22 to 44 g/d for up to 6
wk) resulted in positive changes in body composition (5) and (6). Collectively, these findings
suggest that ingestion of 16 to 44 g/d of calcium
pyruvate may promote weight loss in overweight
populations.
Although these findings support the potential
use of calcium pyruvate as a weight-loss dietary
supplement, the practicality and affordability of
subjects taking large doses of calcium pyruvate
in an attempt to manage body composition has
been questioned (7). For this reason, several research groups have evaluated the effects of ingesting smaller amounts of calcium pyruvate on
weight loss. For example, Kalman et al. (7) reported modest but significant decreases in body
weight and body fat in subjects administered 6
g/d of calcium pyruvate for 6 wk in comparison
with placebo. Conversely, Stone et al. (8) reported that pyruvate supplementation (0.22 g · kg−1 ·
d−1 or about 9 g/d for 5 wk) did not significantly
affect body composition or training adaptations
in college football players.
Although several studies have indicated that
pyruvate supplementation may affect body composition, the mechanisms of action are not fully
understood. One theory proposes that pyruvate
may influence the manner and efficiency in
which ingested foods are used, resulting in en3!!!!!DIGITALCOMMONS@WSU | 2005!

hanced lipolysis and an increased proportion of
energy derived from fat (1). In addition, Newsholme (9) proposed that pyruvate may activate a
futile
cycle,
such
as
the
pyruvatephosphoenolpyruvate cycle, resulting in excess
energy and fat oxidation. However, more research is needed to understand the effects of calcium pyruvate supplementation on appetite, energy intake, energy metabolism, and body composition before conclusions can be drawn. The
purpose of this study was to 1) determine whether calcium pyruvate supplementation affects
body composition in moderately overweight, untrained women who were initiating a standard
exercise program; 2) evaluate the effects of calcium pyruvate supplementation on metabolic responses to maximal and sustained exercise; and 3)
examine the effects of pyruvate supplementation
on clinical chemistry profiles.
MATERIALS AND METHODS
Subjects
Eighty-seven women responded to advertisements posted in local newspapers and on the
campus of the University of Memphis (Memphis,
TN, USA). From this pool, 34 women initially
enrolled in the study. Subjects were informed
about the experimental procedures, they completed medical history and exercise training
forms, and they signed informed consent statements that adhered to guidelines established by
the American College of Sports Medicine and the
institutional review board at the University of
Memphis. Twenty-three healthy, moderately
overweight women completed all aspects of the
study. Subjects were 33 ± 8 y of age, weighed
71.5 ± 11 kg, had a body mass index of 27.4 ± 3
kg/m2, and had a maximal oxygen uptake of 34.4
± 7 mL · kg−1 · min−1. None of the subjects was
involved in a resistance training program for 3
mo before the start of this study. Because data
were collected before and after a 30-d exercise
and nutrition intervention, no specific effort was
made to standardize the start of the study to a
given time of subjects’ menstrual cycles. However, subjects did not start the study during men-
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struation. Most women involved in this study
reported taking oral contraceptives. Subjects who
did not complete the study withdrew or were
withdrawn primarily due to an inability to comply with the study training protocol and/or personal issues.
Experimental design
Subjects were instructed to maintain their normal
diets throughout the study and were not allowed
to ingest any other nutritional supplements (i.e.,
vitamins, minerals, proposed ergogenic aids, etc.).
Baseline assessments were conducted over a 3-d
period and involved participating in two testing
sessions. Before reporting to the laboratory for
baseline testing, subjects recorded dietary intake
(food and liquid) for 4 d. Subjects observed a 4-h
fast before reporting to the laboratory on each
visit. In the first visit, subjects had body mass
and body composition determined, and they performed a maximal cardiopulmonary exercise test
on a treadmill. During the second visit, subjects
reported to the laboratory after a 4-h fast and donated venous blood samples. Subjects rested for
30 min and then performed a 45-min walk test on
a treadmill at a work rate corresponding to 70%
of maximal oxygen uptake. Venous blood samples were also obtained immediately after the
walk test.
Once baseline tests were conducted, subjects
were matched and paired based on body mass,
percentage of body fat, body mass index, age,
and reported activity levels. In a randomized and
double-blind fashion, subjects were then assigned to a pyruvate group or a placebo group.
Subjects ingested 5 g of calcium pyruvate (PYR)
or 5 g of a placebo (PL) that contained 2.5 g of
calcium carbonate, 4 g of maltodextrin, and 1 g
of dextrose two times daily (10 g/d) for 30 d.
Supplements were prepared in powdered form
with similar taste, texture, and appearance and
coded in generic packets for double-blind administration. Subjects were instructed to mix the
supplement powder into approximately 8 oz of
fluid and to ingest the solution two times daily.
Supplement packets were administered in two
15-d supply allotments. Empty packets were col4!!!!!DIGITALCOMMONS@WSU | 2005!

lected from subjects to determine compliance in
taking the supplements. In addition, subjects
completed a questionnaire after the study and
reported a 94% compliance rate in taking the
supplements.
Subjects were then prescribed a 30-d program of resistance training and walking. Resistance training involved performing two sets of
8 to 12 repetitions on eight Nautilus machines
(seated leg press, leg extension, leg curl, bench
press, shoulder press, lateral pull-down, back extension, and abdominal curl) three times per
week. Subjects were instructed to rest approximately 60 s between each set and to complete
both sets of each exercise before continuing to
the next exercise. Once subjects could complete
12 repetitions of an exercise for both sets, they
were instructed to progress to the next machine
weight. Subjects also walked for 30 min at a
work rate equivalent to 70% of maximal oxygen
uptake three times per week. Exercise sessions
were monitored by research assistants and all
workouts were recorded in training logs.
Sessions after testing were conducted over a
3-d period after 30 d of supplementation and
training. All post-testing sessions were conducted in a similar manner as testing before supplementation. Therefore, subjects recorded dietary
intake for the final 4 d of the experimental period,
had their body compositions determined, performed a maximal cardiopulmonary exercise test,
and repeated the 45-min walk test over a 3-d period. Subjects were instructed to consume the
same meal and fluids 4 h before each walk test.
The only difference between testing sessions was
that subjects ingested their assigned supplement
mixed in a non-caloric flavored drink 30 min before donating a pre-exercise blood sample.
Procedures
Nutritional records were interpreted and analyzed
by a registered dietitian using Food Processor III
nutritional analysis software (Nutritional Systems, Salem, OR, USA). Body weight was measured with the subjects dressed in bathing suits
and standing on a calibrated electronic scale with
a precision of ±0.02 kg (Sterling Scale Company,
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Southfield, MI, USA). Body composition was
determined by standard hydrostatic weighing
procedures (10) and a spring-loaded autopsy
scale (Chatillon, New York, NY, USA). Vital
capacity was assessed before underwater submersions with a Quinton Q-Plex metabolic cart
spirometer (Quinton Instruments, Seattle, WA,
USA). Vital capacity was also obtained with a
hand-held spirometer (Micro Medical Limited,
Kent, UK) during each submersion trial to verify
that subject expired all of their air. Subjects performed 8 to 12 consecutive underwater weighing
tests until the highest underwater weight could be
replicated three times. Body composition was
determined by using the average of the best two
trials. Residual lung volume was estimated as 28%
of vital capacity according to standard procedures (10) and (11). Body density and body
composition were then calculated with Siri’s
equation (10).
The maximal cardiopulmonary exercise and
45-min walk tests were performed on a Quinton
Q-55 treadmill attached to a Quinton Q-Plex
metabolic measurement cart (Quinton Instruments). Metabolic analyzers were calibrated to
certified gases, and the Pneumotach was calibrated by using a 3-L volume syringe before each
test according to standard procedures. Bruce’s
maximal exercise test protocol was used to obtain maximal exercise responses. Subjects received verbal encouragement to exercise to the
best of their ability. The test was terminated once
the subjects reached volitional exhaustion according to standard termination criteria. Ventilatory anaerobic thresholds were determined in a
blind manner according to standardized criteria,
namely by the point of non-linear increase in
ventilation, a non-linear increase in carbon dioxide production, and an increase in respiratory exchange ratio (RER) as work rate incrementally
increased (12).
During the 45-min walk test, subjects exercised at a work rate corresponding to 70% of pretraining maximal oxygen uptake. Breath-bybreath oxygen uptake, RER, and exercise heart
rate responses were obtained throughout the walk
test and averaged at 3-min intervals for statistical
5!!!!!DIGITALCOMMONS@WSU | 2005!

analysis. In addition, rating of perceived exertion
was obtained every 5 min during testing.
Blood samples were obtained from an antecubital forearm vein according to standard phlebotomy procedures before and after the walk
tests. Venous blood was collected into two 10mL serum separation tubes and a 5-mL K3 anticoagulation tube that contained ethylenediaminetetra-acetic acid. Serum separation tubes
were centrifuged at 5000 revolutions/min for 10
min with a Biofuge 17R centrifuge (Heraeus Inc.,
Mannheim, Germany). Serum was then separated
from the serum separation tubes, placed in serum
storage containers, and refrigerated until analysis.
The tube that contained ethylene-diaminetetraacetic acid and one serum vial were shipped
overnight in cold containers to Quest Diagnostics
(St. Louis, MO, USA) for clinical analysis. A
complete clinical chemistry panel (31 items) was
run on serum samples by using the Technicon
DAX (model 96-0147, Technicon Inc., Terrytown, NY, USA) automated chemistry analyzer
according to standard clinical procedures. Cell
blood counts with percent differentials were run
on whole blood samples by using a Coulter
STKS automated analyzer (Coulter Inc., Hialeah,
FL, USA) according to standard procedures. The
remaining serum vials were frozen at −80°C until
the end of the study. Non-esterified fatty acids,
glycerol, and β-hydroxybutyrate concentrations
were determined by a Milton-Roy DUV spectrophotometer (Milton-Roy Company, Rochester,
NY, USA) using kits for non-esterified fatty acids (Wako Diagnostic, Richmond, VA, USA) and
for triacylglycerol GPO-trinder and βhydroxybutyrate (Sigma Diagnostic, St. Louis,
MO, USA). Test-to-test reliability of performing
these assays ranged from 2% to 6% for individual assays, with an average variation of ±3%.
Statistical analysis
Data were analyzed by analysis of variance
(ANOVA) for repeated measures with least significant difference post hoc procedures by using
SPSS 11.5 for Windows (SPSS Inc., Chicago, IL,
USA). Interactions between groups were also
examined by calculating Δ scores (values after
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versus before supplementation) and analyzing the
Δ data by one-way ANOVA when only one data
point was analyzed (e.g., changes in body composition data) or by repeated measures ANOVA
when multiple data points were analyzed (e.g.,
changes in mean oxygen uptake and RER values
during the walk test). This procedure yields the
same statistical outcomes as observed in raw data
analysis and has been used in numerous studies
to demonstrate changes observed across groups
in a simple and statistically sound manner. Because determination of body composition using
hydrostatic weighing techniques assesses three
related measurements of body mass, a multivariate ANOVA was run on body composition data
to assess the overall effect of the supplementation protocol on body composition variables to
account for possible experiment-wise error. Data
were considered statistically significant when the
probability of type I error was 0.05 or less. Statistical power and 95% confidence intervals (CIs)
are also presented on selected variables. Data are
presented as means ± standard deviations.
RESULTS
Training volume
No significant differences were observed between groups in total resistance training volume
(PL 49 579 ± 5186 kg, PYR 54 409 ± 3995 kg, P
= 0.47) or total exercise time (PL 347 ± 41 min,
PYR 388 ± 27 min, P = 0.40).
Dietary variables
Table 1 presents dietary intake data for the
PL and PYR groups. No significant differences
were observed between groups in energy intake,
fat intake, protein intake, or carbohydrate intake.
Although not significant, there was some evidence that subjects in the PYR group decreased
energy intake after supplementation (PL −8.0 ± 3
kJ · kg−1 · d−1, PYR −21.5 ± 12 kJ · kg−1 · d−1, P =
0.30).

6!!!!!DIGITALCOMMONS@WSU | 2005!

Body composition
Table 2 presents the body composition data observed between groups, and Fig. 1 presents the
changes observed in body composition variables
from baseline values (i.e., Δ values). Univariate
repeated measures ANOVA showed significant
group × time interactions in body weight (P =
0.04) and body fat (P = 0.03). Changes in percentage of body fat tended to be different (P =
0.07), with no differences observed between
groups in fat-free mass (P = 0.29). Similarly,
one-way ANOVA performed on body composition Δ values showed significant differences between groups in body mass (PL 1.2 ± 0.3 kg, CI
= −0.39–1.0; PYR 0.3 ± 0.3 kg, CI = 0.7–1.8; P
= 0.04) and fat mass (PL 1.1 ± 0.5 kg, CI = 0.03–
2.2; PYR −0.4 ± 0.5 kg, CI = −1.4 to 0.6; P =
0.03), with some evidence that subjects in the
PYR group lost a greater percentage of body fat
(PL 1.0 ± 0.7%, CI = 0.45–2.5; PYR −0.65 ±
0.6%, CI = −1.9 to 0.6; P = 0.07). No significant
differences were observed in changes in fat-free
mass (PL 0.1 ± 0.5 kg, CI = −1.0 to 1.2; PYR 0.7
± 0.3 kg, CI = 0.02–1.4; P = 0.29). However,
four observations should be noted. First, changes
in body composition variables were relatively
minor and well within the typical test-to-test variability (i.e., 5% to 8% using hydrostatic weighing techniques to assess body composition). Second, the significant interactions observed in
body mass and fat mass appeared to have been
influenced to a greater degree by changes observed in the PL group rather than in the PYR
group. Third, multivariate ANOVA of related
body composition variables indicated that there
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was no overall effect on body composition variables (P = 0.16). Fourth, univariate body composition data results would not be considered statistically significant if Bonferroni’s adjustment to the
α level (P < 0.05/3 = P < 0.017) was applied to
account for possible experiment-wise error in
analyzing related body composition submass
measurements. Therefore, the minor changes observed in body composition variables were not
considered statistically significant.

Blood chemistry profiles
No significant or clinically meaningful differences were observed between groups in fasting
urea nitrogen, creatinine, ratio of urea nitrogen to
creatinine, uric acid, glucose, electrolyte status,
total protein, albumin, white blood cells, or types
of lymphocytes. There was some evidence that
muscle and liver enzymes after training and supplementation were lower in the PYR group (creatine kinase 11 ± 18% versus 10 ± 11%, P = 0.97;
lactate dehydrogenase 4 ± 5% versus −9 ± 4%, P
= 0.06; aspartate aminotransferase 16 ± 7% versus −1 ± 7%, P = 0.13; alanine aminotransferase
23 ± 17% versus −21 ± 9%, P = 0.03; γ-glutamyl
transaminase 10 ± 12 % versus −7 ± 6%, P =
0.06). Table 3 presents blood lipid profiles for
the PL and PYR groups. There was some evidence that PYR supplementation during training
cancelled some of the normally positive effects
of exercise on blood lipid profiles (total cholesterol 3 ± 12% versus −2 ± 15%, P = 0.38; highdensity lipoprotein 14 ± 21% versus −6 ± 13%, P
= 0.01; ratio of total cholesterol to high-density
lipoprotein cholesterol −8 ± 16% versus 4 ± 12%,
P = 0.06; low-density lipoprotein 4 ± 25% versus
−7 ± 17%, P = 0.25; very low-density lipoprotein
−9 ± 28% versus 19 ± 59%, P = 0.17; triacylglycerols −13 ± 23% versus 18 ± 60%, P = 0.13).
Maximal exercise capacity
Exercise training significantly increased maximal
oxygen uptake and time to exhaustion by averages of 10.1% and 14%, respectively. However, no
significant differences were observed between
groups in the increases in maximal oxygen uptake, ventilatory anaerobic threshold, RER, heart
rate, or time to exhaustion.

Figure 1.!Changes in TBM, LM, FM, and BF for the placebo group (open bars) and the pyruvate group (solid
bars). ∗ P < 0.05. † Difference of P < 0.10 to P > 0.05.
Data are presented as mean ± standard deviation. BF:
body fat; FM: fat mass; LM: lean mass; TBM: total body
mass.
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Walk test
Fig. 2 presents the changes observed from baseline values in oxygen uptake and RER. No significant differences were observed in mean oxygen uptake values to perform the walk (day 0: PL
1.87 ± 0.26 L/min, PYR 1.71 ± 0.19 L/min; day
30: PL 1.63 ± 0.25 L/min, PYR 1.64 ± 0.20
L/min; P = 0.37 for group, P = 0.003 for time, P
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= 0.08 for group × time). However, there was
some evidence that mean RER values tended to
increase after supplementation in the PYR group
(day 0: PL 0.855 ± 0.04, PYR 0.841 ± 0.04; day
30: PL 0.837 ± 0.03, PYR 0.855 ± 0.03, P =
0.10). Interestingly, the trend toward higher RER
values after PYR supplementation (PL −0.018 ±
0.04, PYR 0.05 ± 0.05, P = 0.10 for group × time)
occurred despite a slight decrease in mean oxygen uptake values to perform the walk (PL −0.24
± 0.27, PYR −0.07 ± 0.14, P = 0.08 for group ×
time). These findings suggest that the subjects
may have developed a slightly higher rate of carbohydrate oxidation during exercise after PYR
supplementation. No significant differences were
observed in concentrations of glycerol, free fatty
acid, and β-hydroxybutyrate between groups.
DISCUSSION
The purpose of this study was to determine
whether calcium pyruvate supplementation significantly affects body composition, metabolic
8!!!!!DIGITALCOMMONS@WSU | 2005!

Figure 2.!Changes in oxygen uptake and respiratory exchange ratio responses from baseline values observed during the walk test for the placebo group (squares) and pyruvate group (diamonds). Data are presented as mean ±
standard deviation.

responses to exercise, or substrate utilization during aerobic exercise in mildly overweight women
who engage in a basic exercise program. The rationale for this study was based on previous findings that indicated that pyruvate supplementation
taken in dosages of up to 44 g/d enhances weight
and fat loss among morbidly obese subjects (1),
(2) and (13), shifts the resting substrate utilization in favor of an increased proportion of energy
derived from fats (1), and elicits a carbohydratesparing effect in athletes, thus enabling them to
improve exercise performance (3) and (4).
Although some statistical trends were observed, the present results indicated that PYR
supplementation (10 g/d for 30 d) does not sig-
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nificantly affect overall changes in body composition during training. The trends observed were
relatively minor and appear to have been influenced to a greater degree to an unexplained increase in body mass and fat mass observed in the
PL group rather than to changes observed in the
PYR group. In addition, changes in body composition values were within the typical test-to-test
reliability of hydrostatic weighing (i.e., 5% to
8%) and therefore may have simply been a result
of standard assessment error. The present findings are in contrast to previous studies that reported that obese subjects who received large
doses of pyruvate (e.g., 16 to 30 g/d) lost 0.8 to
1.3 kg more fat than did the PL group, with no
significant decreases in lean body mass (1), (2),
(14) and (15). Moreover, because of the relatively high cost of calcium pyruvate, one must question whether the minor effects observed on fat
loss (i.e., −0.4 ± 0.5 kg of fat mass) would be
worth the costs associated with taking 10 g/d of
calcium pyruvate.
Although the mechanisms by which pyruvate
might promote weight and fat loss are unknown,
researchers have postulated that it may alter the
manner and efficiency in which ingested foods
are used, resulting in enhanced lipolysis and an
increased proportion of energy derived from fats
(1). Stanko et al. proposed that pyruvate supplementation activates a futile cycle, such as the pyruvate-phosphoenolpyruvate cycle, resulting in
excess energy and lipid expenditure (1). A futile
cycle is produced when a non-equilibrium reaction in the forward direction of a pathway is opposed by another unequal reaction in the reverse
direction. Because a substrate is continuously
converted and reconverted back to its original
form, chemical energy is created and converted
into heat, which is lost in the environment (8).
This theory suggests that exogenously provided
pyruvate may exceed the amount in which the
cells could convert into acetyl coenzyme A. As a
result, supplemental pyruvate may be transformed into oxaloacetate within the Krebs cycle
and then converted back to phosphoenolpyruvate,
the precursor of pyruvate. Through such a futile
cycle, excess energy could theoretically be expended, thereby promoting fat loss.
9!!!!!DIGITALCOMMONS@WSU | 2005!

In the present study, there was no evidence
that the fat loss was attributed to an increase in
fat metabolism. Serum concentrations of free fatty acids and glycerol, which are indicative of
mobilization and breakdown of triacylglycerols,
did not differ significantly between the PYR and
PL groups. Fewer non-esterified fatty acids were
mobilized in response to PYR supplementation,
suggesting less fat mobilization and/or metabolism.
Further,
concentrations
of
βhydroxybutyrate, which is a ketone indicative of
fat metabolism, did not statistically differ between trials or groups. Although the etiology of
these observations remains to be determined, the
exogenous pyruvate could simply have served as
a carbohydrate fuel source during exercise,
thereby decreasing the need to mobilize fat as a
fuel. In support of this contention, previous studies have indicated that pyruvate enabled subjects
to prolong their exercise times by enhancing
fractional glucose extraction during rest and exercise that resulted in the provision of additional
energy substrates (3), (4) and (16). Although this
measurement was not assessed in the present investigation, RER values tended to be higher during the walk test in the PYR group (P = 0.10)
despite a slightly lower oxygen uptake, suggesting greater carbohydrate oxidation. These findings may suggest that the pyruvate can serve as
an exogenous source of carbohydrate during exercise, which may increase carbohydrate oxidation and energy expenditure. However additional
research is necessary to evaluate the effects of
PYR supplementation on substrate utilization
during exercise.
Interestingly, subjects who used PYR developed an increase in fasting serum levels of triacylglycerol and very low-density lipoprotein,
whereas levels of high-density lipoprotein cholesterol were significantly decreased. In this regard, fasting serum triacylglycerol levels were 14%
higher after PYR supplementation, in contrast to
a 14% lower value after training in the PL group.
This pattern was also observed after the subjects
performed the walk test after supplementation.
These results contradict previous findings suggesting that pyruvate supplementation (36 to 53 g)
decreases total cholesterol and low-density lipo-
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protein concentrations by 4% and 5%, respectively, in obese hyperlipidemic patients (17).
Further, they are in agreement with findings of
Ivy et al. (18) who reported that pyruvyl-glycine
supplementation increased plasma triacylglycerols in obese Zucker rats. Ivy et al. (18) hypothesized that the increase in triacylglycerols was be
due to a greater mobilization or decreased clearance of blood lipids in response to consuming the
pyruvyl-glycine diet. Although pre-exercise feeding of calcium pyruvate may have only temporarily increased blood lipids, additional research
should evaluate this potentially negative side effect of PYR supplementation.
The present results indicated that PYR supplementation does not significantly affect maximal exercise capacity, ventilatory anaerobic
threshold, or time to exhaustion. These findings
indicated that PYR supplementation during training does not appear to be an effective ergogenic
aid in women who initiate training.
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